Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy

Journal of the American College of Cardiology

Volumn 39, Issue 2, 2002, Pages 295-300

  Kitamura, Hidetsuna ^a   Ohnishi, Yoshio ^a   Okajima, Katsunori ^a   Ishida, Akihiko ^a   Galeano, Erdulfo Javier ^a   Adachi, Kazumasa ^a   Yokoyama, Mitsuhiro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART DILATATION; HEART RATE VARIABILITY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; T WAVE;

AGED; CARDIOMYOPATHY, DILATED; FEMALE; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 0037116566     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01718-1     Document Type: Article

References (38)

1. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung and Blood Institute workshop)
2. Predictors of mortality from idiopathic dilated cardiomyopathy in 356,222 men screened for the Multiple Risk Factor Intervention trial
3. Sudden unexpected death in patients with congestive heart failure: A second frontier
4. Dilated cardiomyopathy of the adult (first of two parts)
5. Effect of enalapril on mortality in severe congestive heart failure: Results of the cooperative north Scandinavian enalapril survival study (CONSENSUS)
6. The effect of carvedilol on mortality in patients with chronic heart failure: U.S. Carvedilol Heart Failure study group
7. Grupo de estudio de la sobrevia en la insuficiencia cardiaca en Argentina (GESICA): Randomised trial of low-dose amiodarone in severe congestive heart failure
8. Sudden cardiac death: Epidemiology, transient risk, and intervention assessment
9. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia
10. The prognostic significance of quantitative signal-average to variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: A prospective study
11. Usefulness of signal-averaged electrocardiogram in idiopathic dilated cardiomyopathy for identifying patients with ventricular arrhythmias
12. High-gain signal-averaged electrogram combined with 24-h monitoring in patients early after myocardial infarction for bedside prediction of arrhythmic events
13. Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction: A prospective study
14. Heart rate variability and major arrhythmic events in patients with idiopathic dilated cardiomyopathy
15. Decreased heart rate variability in survivors of sudden cardiac death not associated with coronary artery disease
16. Fluctuations in T-wave morphology and susceptibility to ventricular fibrillation
17. Subtle alternating electrocardiographic morphology as an indicator of decreased cardiac electrical stability
18. Electrical alternans and cardiac instability
19. Electrical alternans and vulnerability to ventricular arrhythmias
20. Electrophysiologic basis for T-wave alternans as an index of vulnerability to ventricular fibrillation
21. T-wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: Prospective comparison with conventional risk markers
22. T-wave alternans during exercise and atrial pacing in humans
23. Effect of heart rate on T-wave alternans
24. Occult T-wave alternans in long Q.T syndrome
25. Mechanism linking T-wave alternans to genesis of cardiac fibrillation
26. Determinant of microvolt-level T-wave alternans in patients with dilated cardiomyopathy
27. Predicting sudden cardiac death from T-wave alternans of the surface electrocardiogram: Promise and pitfalls
28. Electrical alternans during rest and exercise as predictors of vulnerability to ventricular arrhythmias
29. Mode of death in idiopathic dilated cardiomyopathy: A multicenter analysis of prognostic determinants
30. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near fetal ventricular arrhythmias
31. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on Pacemaker Implantation)
32. Prognostic significance of electrical alternans versus averaged electrocardiography in predicting the outcome of electrophysiological testing and arrhythmia-free survival
33. Value of time- and frequency-domain analysis of signal-averaged electrocardiography for arrhythmia risk prediction in idiopathic dilated cardiomyopathy
34. Arrhythmia risk stratification in idiopathic dilated cardiomyopathy based on echocardiography and 12-lead, signal-averaged, and 24-hour Holter electrocardiography
35. Noninvasive arrhythmia risk stratification in idiopathic cardiomyopathy: Design and first results of the Marburg cardiomyopathy study
36. Cellular and ionic basis for T-wave alternans under long-QT condition
37. Risk stratification for sudden cardiac death in dilated cardiomyopathy using microvolt-level T-wave alternans
38. T-wave alternans as a risk predictor in patients with cardiomyopathy and mild-to-moderate heart failure